Clinical Trial: Biomarker for Metachromatic Leukodystrophy Disease

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Biomarker for Metachromatic Leukodystrophy Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL

Brief Summary: Development of a new MS-based biomarker for the early and sensitive diagnosis of metachromatic leukodystrophy disease from plasma. Testing for clinical robustness, specificity and long-term stability of the biomarker.